;PMID: 8938131
;source_file_2917.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..32] = [t:0..32]
;1)sentence:[e:38..147] = [t:38..147]
;2)section:[e:151..369] = [t:151..369]
;3)section:[e:373..479] = [t:373..479]
;4)sentence:[e:483..633] = [t:483..633]
;5)sentence:[e:634..871] = [t:634..871]
;6)sentence:[e:873..1182] = [t:873..1182]
;7)sentence:[e:1183..1421] = [t:1183..1421]
;8)section:[e:1425..1469] = [t:1425..1469]

;section 0 Span:0..32
;Neuron.  1996 Nov;17(5):1005-13.
(SEC
  (FRAG (NNP:[0..6] Neuron) (.:[6..7] .) (CD:[9..13] 1996)
        (IN:[14..21] Nov;17-LRB-) (CD:[21..22] 5) (-RRB-:[22..23] -RRB-)
        (::[23..24] :) (CD:[24..28] 1005) (CD:[28..31] -13) (.:[31..32] .)))

;sentence 1 Span:38..147
;Familial Alzheimer's disease-linked presenilin 1 variants elevate
;Abeta1-42/1-40  ratio in vitro and in vivo.
;[74..86]:gene-rna:"presenilin 1"
;[104..113]:gene-protein:"Abeta1-42"
;[114..118]:gene-protein:"1-40"
(SENT
  (S-HLN
    (NP-SBJ
      (ADJP
        (NML
          (NP (JJ:[38..46] Familial) (NNP:[47..56] Alzheimer) (POS:[56..58] 's))
          (NN:[59..66] disease))
        (HYPH:[66..67] -) (VBN:[67..73] linked))
      (NML (NN:[74..84] presenilin) (CD:[85..86] 1))
      (NNS:[87..95] variants))
    (VP (VBP:[96..103] elevate)
      (NP
        (NML
          (NML (NN:[104..109] Abeta) (CD:[109..110] 1) (HYPH:[110..111] -)
               (CD:[111..113] 42))
          (PP (SYM:[113..114] /)
            (NP (CD:[114..115] 1) (HYPH:[115..116] -) (CD:[116..118] 40))))
        (NN:[120..125] ratio))
      (ADVP
        (ADVP (FW:[126..128] in) (FW:[129..134] vitro))
        (CC:[135..138] and)
        (ADVP (FW:[139..141] in) (FW:[142..146] vivo))))
    (.:[146..147] .)))

;section 2 Span:151..369
;Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T,
;Prada  CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI,
;Gandy SE,  Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS.
(SEC
  (FRAG (NNP:[151..159] Borchelt) (NNP:[160..162] DR) (,:[162..163] ,)
        (NNP:[164..174] Thinakaran) (NNP:[175..176] G) (,:[176..177] ,)
        (NNP:[178..184] Eckman) (NNP:[185..187] CB) (,:[187..188] ,)
        (NNP:[189..192] Lee) (NNP:[193..195] MK) (,:[195..196] ,)
        (NNP:[197..206] Davenport) (NNP:[207..208] F) (,:[208..209] ,)
        (NNP:[210..220] Ratovitsky) (NNP:[221..222] T) (,:[222..223] ,)
        (NNP:[224..229] Prada) (NNP:[231..233] CM) (,:[233..234] ,)
        (NNP:[235..238] Kim) (NNP:[239..240] G) (,:[240..241] ,)
        (NNP:[242..249] Seekins) (NNP:[250..251] S) (,:[251..252] ,)
        (NNP:[253..258] Yager) (NNP:[259..260] D) (,:[260..261] ,)
        (NNP:[262..267] Slunt) (NNP:[268..270] HH) (,:[270..271] ,)
        (NNP:[272..276] Wang) (NNP:[277..278] R) (,:[278..279] ,)
        (NNP:[280..286] Seeger) (NNP:[287..289] M,) (NNP:[290..295] Levey)
        (NNP:[296..298] AI) (,:[298..299] ,) (NNP:[300..305] Gandy)
        (NNP:[306..308] SE) (,:[308..309] ,) (NNP:[311..319] Copeland)
        (NNP:[320..322] NG) (,:[322..323] ,) (NNP:[324..331] Jenkins)
        (NN:[332..334] NA) (,:[334..335] ,) (NNP:[336..341] Price)
        (NNP:[342..344] DL) (,:[344..345] ,) (NNP:[346..353] Younkin)
        (NNP:[354..356] SG) (,:[356..357] ,) (NNP:[358..365] Sisodia)
        (NNP:[366..368] SS) (.:[368..369] .)))

;section 3 Span:373..479
;Department of Pathology, The Johns Hopkins University School of Medicine, 
;Baltimore, Maryland 21205, USA.
(SEC
  (FRAG (NNP:[373..383] Department) (IN:[384..386] of)
        (NNP:[387..396] Pathology) (,:[396..397] ,) (DT:[398..401] The)
        (NNP:[402..407] Johns) (NNP:[408..415] Hopkins)
        (NNP:[416..426] University) (NNP:[427..433] School) (IN:[434..436] of)
        (NNP:[437..445] Medicine) (,:[445..446] ,) (NNP:[448..457] Baltimore)
        (,:[457..458] ,) (NNP:[459..467] Maryland) (CD:[468..473] 21205)
        (NNP:[473..474] ,) (NNP:[475..478] USA) (.:[478..479] .)))

;sentence 4 Span:483..633
;Mutations in the presenilin 1 (PS1) and presenilin 2 genes cosegregate with
;the  majority of early-onset familial Alzheimer's disease (FAD) pedigrees.
;[500..512]:gene-rna:"presenilin 1"
;[514..517]:gene-rna:"PS1"
;[523..535]:gene-rna:"presenilin 2"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[483..492] Mutations))
      (PP (IN:[493..495] in)
        (NP (DT:[496..499] the)
          (NML
            (NML
              (NML
                (NML (NN:[500..510] presenilin) (CD:[511..512] 1))
                (NML (-LRB-:[513..514] -LRB-) (NN:[514..517] PS1)
                     (-RRB-:[517..518] -RRB-)))
              (NML-1 (-NONE-:[518..518] *P*)))
            (CC:[519..522] and)
            (NML
              (NML (NN:[523..533] presenilin) (CD:[534..535] 2))
              (NML-1 (NNS:[536..541] genes)))))))
    (VP (VBP:[542..553] cosegregate)
      (PP (IN:[554..558] with)
        (NP
          (NP (DT:[559..562] the) (NN:[564..572] majority))
          (PP (IN:[573..575] of)
            (NP
              (NML (JJ:[576..581] early) (HYPH:[581..582] -)
                   (NN:[582..587] onset))
              (NML
                (NML (JJ:[588..596] familial)
                  (NP (NNP:[597..606] Alzheimer) (POS:[606..608] 's))
                  (NN:[609..616] disease))
                (NML (-LRB-:[617..618] -LRB-) (NN:[618..621] FAD)
                     (-RRB-:[621..622] -RRB-)))
              (NNS:[623..632] pedigrees))))))
    (.:[632..633] .)))

;sentence 5 Span:634..871
;We now  document that the Abeta1-42(43)/Abeta1-40 ratio in the conditioned
;media of  independent N2a cell lines expressing three FAD-linked PS1 variants
;is uniformly  elevated relative to cells expressing similar levels of
;wild-type PS1.
;[660..673]:gene-protein:"Abeta1-42(43)"
;[674..683]:gene-protein:"Abeta1-40"
;[774..777]:gene-rna:"PS1"
;[867..870]:gene-rna:"PS1"
(SENT
  (S
    (NP-SBJ (PRP:[634..636] We))
    (ADVP (RB:[637..640] now))
    (VP (VBP:[642..650] document)
      (SBAR (IN:[651..655] that)
        (S
          (NP-SBJ-1
            (NP
              (NML
                (NML (DT:[656..659] the)
                   (NN:[660..665] Abeta) (CD:[665..666] 1) (HYPH:[666..667] -)
                   (CD:[667..669] 42)
                  (PRN (-LRB-:[669..670] -LRB-)
                    (NP (CD:[670..672] 43))
                    (-RRB-:[672..673] -RRB-)))
                (PP (SYM:[673..674] /)
                  (NP (NN:[674..679] Abeta) (CD:[679..680] 1)
                      (HYPH:[680..681] -) (CD:[681..683] 40))))
              (NN:[684..689] ratio))
            (PP (IN:[690..692] in)
              (NP
                (NP (DT:[693..696] the) (VBN:[697..708] conditioned)
                    (NNS:[709..714] media))
                (PP (IN:[715..717] of)
                  (NP
                    (NP (JJ:[719..730] independent) (NN:[731..734] N2a)
                        (NN:[735..739] cell) (NNS:[740..745] lines))
                    (VP (VBG:[746..756] expressing)
                      (NP (CD:[757..762] three)
                        (ADJP (NN:[763..766] FAD) (HYPH:[766..767] -)
                              (VBN:[767..773] linked))
                        (NN:[774..777] PS1) (NNS:[778..786] variants))))))))
          (VP (VBZ:[787..789] is)
            (ADVP (RB:[790..799] uniformly))
            (VP (VBN:[801..809] elevated)
              (NP-1 (-NONE-:[809..809] *))
              (S-ADV
                (NP-SBJ (-NONE-:[809..809] *))
                (ADJP-PRD (JJ:[810..818] relative)
                  (PP (TO:[819..821] to)
                    (NP
                      (NP (NNS:[822..827] cells))
                      (VP (VBG:[828..838] expressing)
                        (NP
                          (NP (JJ:[839..846] similar) (NNS:[847..853] levels))
                          (PP (IN:[854..856] of)
                            (NP
                              (NML (JJ:[857..861] wild) (HYPH:[861..862] -)
                                   (NN:[862..866] type))
                              (NN:[867..870] PS1))))))))))))))
    (.:[870..871] .)))

;sentence 6 Span:873..1182
;Similarly, the Abeta1-42(43)/Abeta1-40 ratio is elevated in the brains of
;young  transgenic animals coexpressing a chimeric amyloid precursor protein
;(APP) and  an FAD-linked PS1 variant compared with brains of transgenic mice
;expressing APP  alone or transgenic mice coexpressing wild-type human PS1 and
;APP.
;[888..901]:gene-protein:"Abeta1-42(43)"
;[902..911]:gene-protein:"Abeta1-40"
;[997..1022]:gene-protein:"amyloid precursor protein"
;[1024..1027]:gene-protein:"APP"
;[1048..1051]:gene-rna:"PS1"
;[1111..1114]:gene-protein:"APP"
;[1170..1173]:gene-rna:"PS1"
;[1178..1181]:gene-generic:"APP"
(SENT
  (S
    (ADVP (RB:[873..882] Similarly))
    (,:[882..883] ,)
    (NP-SBJ-1 (DT:[884..887] the)
      (NML
        (NML (NN:[888..893] Abeta) (CD:[893..894] 1) (HYPH:[894..895] -)
             (CD:[895..897] 42)
          (PRN (-LRB-:[897..898] -LRB-)
            (NP (CD:[898..900] 43))
            (-RRB-:[900..901] -RRB-)))
        (PP (SYM:[901..902] /)
          (NP (NN:[902..907] Abeta) (CD:[907..908] 1) (HYPH:[908..909] -)
              (CD:[909..911] 40))))
      (NN:[912..917] ratio))
    (VP (VBZ:[918..920] is)
      (VP (VBN:[921..929] elevated)
        (NP-1 (-NONE-:[929..929] *))
        (PP-LOC (IN:[930..932] in)
          (NP
            (NP (DT:[933..936] the) (NNS:[937..943] brains))
            (PP (IN:[944..946] of)
              (NP
                (NP (JJ:[947..952] young) (JJ:[954..964] transgenic)
                    (NNS:[965..972] animals))
                (VP (VBG:[973..985] coexpressing)
                  (NP
                    (NP (DT:[986..987] a) (JJ:[988..996] chimeric)
                      (NML
                        (NML (JJ:[997..1004] amyloid)
                             (NN:[1005..1014] precursor)
                             (NN:[1015..1022] protein))
                        (NML (-LRB-:[1023..1024] -LRB-) (NN:[1024..1027] APP)
                             (-RRB-:[1027..1028] -RRB-))))
                    (CC:[1029..1032] and)
                    (NP (DT:[1034..1036] an)
                      (ADJP (NN:[1037..1040] FAD) (HYPH:[1040..1041] -)
                            (VBN:[1041..1047] linked))
                      (NN:[1048..1051] PS1) (NN:[1052..1059] variant)))
                  (S-ADV
                    (NP-SBJ-2 (-NONE-:[1059..1059] *))
                    (VP (VBN:[1060..1068] compared)
                      (NP-2 (-NONE-:[1068..1068] *))
                      (PP-CLR (IN:[1069..1073] with)
                        (NP
                          (NP (NNS:[1074..1080] brains))
                          (PP (IN:[1081..1083] of)
                            (NP
                              (NP
                                (NP (JJ:[1084..1094] transgenic)
                                    (NNS:[1095..1099] mice))
                                (VP (VBG:[1100..1110] expressing)
                                  (NP
                                    (NP (NN:[1111..1114] APP))
                                    (ADVP (RB:[1116..1121] alone)))))
                              (CC:[1122..1124] or)
                              (NP
                                (NP (JJ:[1125..1135] transgenic)
                                    (NNS:[1136..1140] mice))
                                (VP (VBG:[1141..1153] coexpressing)
                                  (NP
                                    (NML (JJ:[1154..1158] wild)
                                         (HYPH:[1158..1159] -)
                                         (NN:[1159..1163] type))
                                    (JJ:[1164..1169] human)
                                     (NN:[1170..1173] PS1) (CC:[1174..1177] and)
                                     (NN:[1178..1181] APP)))))))))))))))))
    (.:[1181..1182] .)))

;sentence 7 Span:1183..1421
;These studies  provide compelling support for the view that one mechanism by
;which these mutant  PS1 cause AD is by increasing the extracellular
;concentration of Abeta peptides  terminating at 42(43), species that foster
;Abeta deposition.
;[1280..1283]:gene-rna:"PS1"
;[1345..1350]:gene-protein:"Abeta"
;[1404..1409]:gene-protein:"Abeta"
(SENT
  (S
    (NP-SBJ (DT:[1183..1188] These) (NNS:[1189..1196] studies))
    (VP (VBP:[1198..1205] provide)
      (NP
        (NP (VBG:[1206..1216] compelling) (NN:[1217..1224] support))
        (PP (IN:[1225..1228] for)
          (NP (DT:[1229..1232] the) (NN:[1233..1237] view)
            (SBAR (IN:[1238..1242] that)
              (S
                (NP-SBJ
                  (NP (CD:[1243..1246] one) (NN:[1247..1256] mechanism))
                  (SBAR
                    (WHPP-2 (IN:[1257..1259] by)
                      (WHNP (WDT:[1260..1265] which)))
                    (S
                      (NP-SBJ (DT:[1266..1271] these) (JJ:[1272..1278] mutant)
                              (NNS:[1280..1283] PS1))
                      (VP (VBP:[1284..1289] cause)
                        (NP (NN:[1290..1292] AD))
                        (PP-2 (-NONE-:[1292..1292] *T*))))))
                (VP (VBZ:[1293..1295] is)
                  (PP-MNR-PRD (IN:[1296..1298] by)
                    (S-NOM
                      (NP-SBJ (-NONE-:[1298..1298] *))
                      (VP (VBG:[1299..1309] increasing)
                        (NP
                          (NP (DT:[1310..1313] the)
                              (JJ:[1314..1327] extracellular)
                              (NN:[1328..1341] concentration))
                          (PP (IN:[1342..1344] of)
                            (NP
                              (NP
                                (NP (NN:[1345..1350] Abeta)
                                    (NNS:[1351..1359] peptides))
                                (VP (VBG:[1361..1372] terminating)
                                  (PP-LOC (IN:[1373..1375] at)
                                    (NP (CD:[1376..1378] 42)
                                      (PRN (-LRB-:[1378..1379] -LRB-)
                                        (NP (CD:[1379..1381] 43))
                                        (-RRB-:[1381..1382] -RRB-))))))
                              (,:[1382..1383] ,)
                              (NP
                                (NP (NNS:[1384..1391] species))
                                (SBAR
                                  (WHNP-1 (WDT:[1392..1396] that))
                                  (S
                                    (NP-SBJ-1 (-NONE-:[1396..1396] *T*))
                                    (VP (VBP:[1397..1403] foster)
                                      (NP (NN:[1404..1409] Abeta)
                                          (NN:[1410..1420] deposition)))))))))))))))))))
    (.:[1420..1421] .)))

;section 8 Span:1425..1469
;PMID: 8938131 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1425..1429] PMID) (::[1429..1430] :) (CD:[1431..1438] 8938131)
        (NN:[1439..1440] -LSB-) (NNP:[1440..1446] PubMed) (::[1447..1448] -)
        (NN:[1449..1456] indexed) (IN:[1457..1460] for)
        (NNP:[1461..1469] MEDLINE-RSB-)))
